GGrantIndex
← Search

DEVELOPMENTAL FUNDS

$757,561P30FY2012CANIH

Univ Of Med/Dent Nj-R W Johnson Med Sch, Piscataway NJ

Investigators

Linked publications, trials & patents

Trial NCT05639972Trial NCT05483491Trial NCT05296421Trial NCT04929015Trial NCT04920344Trial NCT04871516Trial NCT04751747Trial NCT04445844Trial NCT04294264Trial NCT04285268Trial NCT04253483Trial NCT04211259Trial NCT04179227Trial NCT04163952Trial NCT04146038Trial NCT04081688Trial NCT03902379Trial NCT03725449Trial NCT03677739Trial NCT03456843Trial NCT03448224Trial NCT03441321Trial NCT03428802Trial NCT03272633Trial NCT03257163Trial NCT03233555Trial NCT03229278Trial NCT03228147Trial NCT03112668Trial NCT03108911Trial NCT03102060Trial NCT03061175Trial NCT03028948Trial NCT02949284Trial NCT02885649Trial NCT02748564Trial NCT02699996Trial NCT02688517Trial NCT02688192Trial NCT02621398Trial NCT02526511Trial NCT02526498Trial NCT02458716Trial NCT02421575Trial NCT02420652Trial NCT02324621Trial NCT02324608Trial NCT02315196Trial NCT02295540Trial NCT02294617Trial NCT02250781Trial NCT02203604Trial NCT02203578Trial NCT02177838Trial NCT02144701Trial NCT02144675Trial NCT02105116Trial NCT01828476Trial NCT01694589Trial NCT01652014Trial NCT01649947Trial NCT01480154Trial NCT01417286Trial NCT01407562Trial NCT01303341Trial NCT01251172Trial NCT01032590Trial NCT01018836Trial NCT01009931Trial NCT01006369Trial NCT00996359Trial NCT00991315Trial NCT00966667Trial NCT00962845Trial NCT00946283Trial NCT00943709Trial NCT00939380Trial NCT00934895Trial NCT00909909Trial NCT00905918Trial NCT00900120Trial NCT00899808Trial NCT00899639Trial NCT00895115Trial NCT00891969Trial NCT00878657Trial NCT00866840Trial NCT00853125Trial NCT00813423Trial NCT00786682Trial NCT00770419Trial NCT00770055Trial NCT00769652Trial NCT00765765Trial NCT00749437Trial NCT00740805Trial NCT00728845Trial NCT00726596Trial NCT00669734Trial NCT00667901

Abstract

Developmental Funds are used to foster outstanding cancer research. During the last grant period, Developmental Funds provided essential support for eight outstanding new investigators, supported 31 pilot studies, and helped establish three new Shared Resources. In particular. Developmental Funds helped to strengthen the Division of Public Health Science and Improved interactions between this division and the Divisions of Basic and Clinical Sciences. During the next grant period, CINJ will use Developmental Funds to continue to enhance each of the established research Programs of the center: Cell Death and Survival Signaling; Genomic Instability and Tumor Progression; Cancer Pharmacology and Preclinical Therapeutics; Clinical Investigations; Carcinogenesis and Chemoprevention; and Cancer Prevention and Control. To accomplish this aim. Developmental Funds will be used to help recruit new investigators, develop new Shared Resources, and fund additional pilot projects aimed at fostering transdisciplinary and translational collaborations, within four major CINJ strategic initiatives: (1) to enhance translational research; (2) to enhance basic science depth through collaborative activity with consortium members; (3) to enhance bioinformatics and systems biology through strategic recruitment of bioinformatics and integration of computational biology faculty; and (4) to develop population science research through recruitment and pilot awards, and the incorporation of the State's cancer registry and research into CINJ. The identification of opportunities for developmental funds that are high yield, and possibly high risk, are developed by the Scientific Council, with advice from the internal and External Advisory Boards (see also Section 7.4). We are requesting a total of $600,000 per year in the Developmental Funds category from the CCSG. Specifically, we are requesting $150,000 toward recruitment and support of new faculty level scientists in areas of strategic need; (2) $225,000 to support pilot projects in high-priority and translational research areas; and (3) $225,000 to develop new Shared Resources ($75,000 each for Small Animal Imaging, Metabolomics, and Epidemiology Services) that align with CINJ's scientific growth and needs.

View original record on NIH RePORTER →